MWK are delighted to advise that Provocholine has recently been granted a licence for the UK market


More news to follow

Provocholine is available in the UK on a named patient only basis.

Provocholine® (methacholine chloride) is indicated for the diagnosis of bronchial airway hyperresponsiveness in subjects who do not have clinically apparent asthma.

The Provocholine® Challenge provides for a sensitive and generally accurate diagnosis of bronchial hyperreactivity as well as the severity of asthma.  The Provocholine® Challenge can also be used to confirm occupational asthma.